-
Specialties
- Lung Transplant
- Pulmonary
- Advanced Lung Disease
- Acute Respiratory Distress Syndrome (ARDS)
- Asthma
- Autoimmune Lung Disease
- Chronic Obstructive Pulmonary Disease
- Critical Care
- Cystic Fibrosis
- Interstitial Lung Disease
- Lung Transplantation after COVID-19
- Post COVID-19 Pulmonary Fibrosis
- Pulmonary Fibrosis
- Pulmonary Function
- Pulmonary Vascular Disease
- Respiratory Critical Care
- Sarcoidosis, Pulmonary
Board Certification
American Board of Internal Medicine (Sub: Critical Care Medicine)American Board of Internal Medicine (Sub: Pulmonary Disease)Patient Rating
4.9 /5( out of 44 reviews )The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.
The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient Comments
Patient comments are gathered from our patient experience survey and displayed in their entirety.
Patients are de-identified for confidentiality and patient privacy.March 20, 2024UH HOSPITALS AND CLINICSDr Raman took the time to explain things so we could understand them. He answered all of our questions and was willing to spend as much time as needed to help us understand everything about my heath and the transplant process .
February 18, 2024UH HOSPITALS AND CLINICSAn amazing Doctor , the University and the patients are lucky to have him on staff
February 10, 2024UH HOSPITALS AND CLINICSHes a wonderful man and doctor. Really cares about the pt and takes all the time you need to visit and ask questions. Never in a hurry. I truly appreciate him.
February 08, 2024UH HOSPITALS AND CLINICSExcellent Doc, takes the time to explain.
February 04, 2024UH HOSPITALS AND CLINICSHe is a focused Dr with a straightforward and honest manner yet conveys empathy and concern. I found him very impressive on first meeting and that grew over time.
January 15, 2024UH HOSPITALS AND CLINICSHe is an awesome Doctor very caring and informative.
December 10, 2023UH HOSPITALS AND CLINICSDr. Roman was excellent in explaining the process of lung transplant. Both the expectations and the risks that involve my two diseases. He was patient and explaining aspects I didn¿t understand, and and being very honest about the expectations and the duration of the process.
December 07, 2023UH HOSPITALS AND CLINICSDr Raman is awesome
October 12, 2023UH HOSPITALS AND CLINICSVery good patient doctor relationship couldn¿t ask for a better one
-
Board Certification and Academic Information
Academic Departments Internal Medicine -Primary Academic Divisions Public Health
Board Certification American Board of Internal Medicine (Sub: Critical Care Medicine)American Board of Internal Medicine (Sub: Pulmonary Disease)Education history
Fellowship Pulmonary/Critical Care - Baylor College of Medicine Fellow Internal Medicine - Michigan State University Chief Resident Residency Internal Medicine - Michigan State University Resident Internal Medicine - Michigan State University Intern Professional Medical Medical School - Grant Medical College M.B.B.S. Medical School - University of Mumbai, Dr. D.Y. Patil Medical College M.B.B.S. Undergraduate R. N Ruia College of Arts & Science Higher Secondary Certificate Selected Publications
Journal Article
- Esther CR Jr, ONeal WK, Anderson WH, Kesimer M, Ceppe A, Doerschuk CM, Alexis NE, Hastie AT, Barr RG, Bowler RP, Wells JM, Oelsner EC, Comellas AP, Tesfaigzi Y, Kim V, Paulin LM, Cooper CB, Han MK, Huang YJ, Labaki WW, Curtis JL, Boucher RC Subpopulations and Intermediate Outcome Measures in COPD Study Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPD Chest 2022 May16151239-1249 doi 101016jchest202110049 Epub 2021 Nov 18 PMID 34801592 PMCID PMC9131049 (2022). Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPD. Chest, 161(5), 1239-1249.
- Marczin N, De Waal EEC et al (2021). International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document. J Heart Lung Transplant, 40(11), 1327-1348.
- Bermudez CA, Crespo MM, Shlobin OA, Cantu E, Mazurek JA, Levine D, Gutsche J, Kanwar M, Dellgren G, Bush EL, Heresi GA, Cypel M, Hadler R, Kolatis N, Franco V, Benvenuto L, Mooney J, Pipeling M, King C, Mannem H, Raman S, Knoop C, Douglas A, Mercier O (2021). ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part II: Cardiac, surgical, perioperative, operative, and post-operative challenges and management statements. J Heart Lung Transplant, 40(11), 1267-1278. (Read full article)
- Bermudez CA, Crespo MM, Shlobin OA, Cantu E, Mazurek JA, Levine D, Gutsche J, Kanwar M, Dellgren G, Bush EL, Heresi GA, Cypel M, Hadler R, Kolatis N, Franco V, Benvenuto L, Mooney J, Pipeling M, King C, Mannem H, Raman S, Knoop C, Douglas A, Mercier O (2021). Bermudez CA, Crespo MM, Shlobin OA, Cantu E, Mazurek JA, Levine D, Gutsche J, Kanwar M, Dellgren G, Bush EL, Heresi GA, Cypel M, Hadler R, Kolatis N, Franco V, Benvenuto L, Mooney J, Pipeling M, King C, Mannem H, Raman S, Knoop C, Douglas A, Mercier O. ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part II: Cardiac, surgical, perioperative, operative, and post-operative challenges and management statements. J Heart Lung Transplant. 2021 Nov;40(11):1267-1278. doi: 10.1016/j.healun.2021.07.016. Epub 2021 Jul 29. PMID: 34404570. J Heart Lung Transplant, 40(11), 1267-1278.
- Aberegg SK, Cirulis MM, Maddock SD, Freeman A, Keenan LM, Pirozzi CS, Raman SM, Schroeder J, Mann H, Callahan SJ (2020). Clinical, Bronchoscopic, and Imaging Findings of e-Cigarette, or Vaping, Product Use-Associated Lung Injury Among Patients Treated at an Academic Medical Center. JAMA Netw Open, 3(11), e2019176. (Read full article)
- Cahill BC, Raman S, Stringham JR, McKellar SH, Selzman CH, Liou TG (2018). Longer Life or More Life: Choose One Please. J Surg Res, 237, 126-128. (Read full article)
- Wells JM, Arenberg DA, Barjaktarevic I, Bhatt SP, Bowler RP, Christenson SA, Couper DJ, Dransfield MT, Han MK, Hoffman EA, Kaner RJ, Kim V, Kleerup E, Martinez FJ, Moore WC, OBeirne SL, Paine R 3rd, Putcha N, Raman SM, Barr RG, Rennard SI, Woodruff PG, Curtis JL (2019). Safety and Tolerability of Comprehensive Research Bronchoscopy in Chronic Obstructive Pulmonary Disease. Results from the SPIROMICS Bronchoscopy Substudy. Ann Am Thorac Soc, 16(4), 439-446. (Read full article)
- McKellar SH, Bowen ME, Baird BC, Raman S, Cahill BC, Selzman CH (Summer 2016). Lung transplantation following coronary artery bypass surgery-improved outcomes following single-lung transplant.J Heart Lung Transplant. 2016 Nov;35(11):1289-1294. doi: 10.1016/j.healun.2016.05.029. Epub 2016 Jun 14. J Heart Lung Transplant, 35(11), 1289-1294.
- Couper D1, LaVange LM, Han M, Barr RG, Bleecker E, Hoffman EA, Kanner R, Kleerup E, Martinez FJ, Woodruff PG, Rennard S SPIROMICS Research Group Collaborators Alexis N, Anderson W, Badr S, Basta P, Boucher RC, Carretta E, Cooper CB, Curtis J, Doerschuk C, Greenberg J, Hansel N, Kaner R, Kesimer M, Lazarus SC, Meyers D, ONeal W, Paine R, Peters SP, Raman S, Scholand MB, Sundar K, Tashkin DP, Wise RA, Wright FA (2014). Title: Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). Authors: Couper D(1), LaVange LM, Han M, Barr RG, Bleecker E, Hoffman EA, Kanner R, Kleerup E, Martinez FJ, Woodruff PG, Rennard S; SPIROMICS Research Group. Collaborators: Alexis N, Anderson W, Badr S, Basta P, Boucher RC, Carretta E, Cooper CB, Curtis J, Doerschuk C, Greenberg J, Hansel N, Kaner R, Kesimer M, Lazarus SC, Meyers D, O'Neal W, Paine R, Peters SP, Raman S, Scholand MB, Sundar K, Tashkin DP, Wise RA, Wright FA. Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) is a multicentre observational study of chronic obstructive pulmonary disease (COPD) designed to guide future development of therapies for COPD by providing robust criteria for subclassifying COPD participants into groups most likely to benefit from a given therapy during a clinical trial, and identifying biomarkers/phenotypes that can be used as intermediate outcomes to reliably predict clinical benefit during therapeutic trials. The goal is to enrol 3200 participants in four strata. Participants undergo a baseline visit and three annual follow-up examinations, with quarterly telephone calls. Adjudication of exacerbations and mortality will be undertaken. DOI: 10.1136/thoraxjnl-2013-203897 PMID: 24029743 [Indexed for MEDLINE]. Thorax.
Review
- Liou TG, Raman SM, Cahill BC (2013). Lung transplantation for chronic obstructive pulmonary disease. [Review]. 5, 1-20.
Book Chapter
- Raman SM, Morrell MR (2017). Respiratory Conditions: Dyspnea. In Sole A, Silveira F (Eds.), ISHLT Monograph Series, Volume 10: What to do in case of...A reference Diagnostic Guide in Thoracic Organ Transplantation: Practical Approach to Frequent Scenarios. Addison, TX: International Society for Heart and Lung Transplantation.
Letter
- Maddock SD, Cirulis MM, Callahan SJ, Keenan LM, Pirozzi CS, Raman SM, Aberegg SK (2019). Pulmonary Lipid-Laden Macrophages and Vaping. [Letter to the editor]. N Engl J Med, 381(15), 1488-1489. (Read full article)
Abstract
- Cahill BC, Liou TG, Peterson-Short K, Maughan T, Doidge W, Sirandas B, Carlson A, Truax C, Cotiguala L, Raman S, McKellar SH, Selzman CH (April 2017). Post-Lung Transplant Survival After Venous Thromboembolism [Abstract]. ISHLT 37th Annual Meeting and Scientific Sessions, 36(4), S403.
-
News & Podcasts